Healthcare / Medical Care FacilitiesNYSE
$2.75
+0.01 (+0.18%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $120.0M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$388M
P/E
0.8x
↓EV/EBITDA
5.5x
↓ROE
-36.5%
↓Gross Margin
85.1%
↑Debt/Equity
-7.92
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
-3.2%
FCF margin
1.7%
FCF / Net income
0.41x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $12.48B · net income $509.0M · FCF $208.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $12.48B | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | — | — | — | — | — | — | — | — |
| Net Income | $509.0M | $509.0M | $-516.0M | $-133.0M | $46.0M | $230.0M | $511.0M | $-675.0M | $-788.0M | $-2.46B | $-1.72B | $158.0M | $92.0M | $141.0M | $266.0M | $201.9M | $280.0M | $243.2M | $218.3M |
| EBITDA | $2.02B | $2.02B | $1.07B | $1.54B | $1.74B | $1.94B | $1.68B | $1.26B | $908.0M | $-1.02B | $240.0M | $2.51B | $2.53B | $1.70B | $1.95B | $1.79B | $1.73B | $1.63B | $1.48B |
| EPS | 3.77 | 3.77 | -3.90 | -1.02 | 0.35 | 1.76 | 4.39 | -5.93 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.25 | 2.45 | 1.84 | 2.49 | 2.20 | 1.92 |
| Gross Margin | 85.1% | 85.1% | 84.6% | 84.0% | 83.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 8.7% | 8.7% | 6.7% | 7.0% | 5.9% | 11.3% | 9.6% | 4.9% | 1.5% | -12.2% | -4.7% | — | — | — | — | — | — | — | — |
| Net Margin | 4.1% | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | 4.3% | -5.1% | -5.6% | -16.0% | -9.3% | — | — | — | — | — | — | — | — |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | -7.92 | -7.92 | -6.32 | -8.75 | -9.06 | -8.83 | -7.44 | -6.03 | -8.72 | -18.14 | 9.44 | 4.24 | 4.23 | 3.08 | 3.49 | 3.69 | — | — | — |
| Current Ratio | 1.47 | 1.47 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $208.0M | $208.0M | $120.0M | $-257.0M | $-115.0M | $-600.0M | $1.74B | $-53.0M | $-253.0M | $209.0M | $393.0M | $-32.0M | $762.0M | $475.0M | $511.0M | $485.2M | $521.4M | $499.5M | $364.3M |
| Returns | |||||||||||||||||||
| ROE | -36.5% | -36.5% | 27.0% | 9.6% | -3.4% | -16.8% | -31.4% | 30.4% | 51.3% | 320.6% | -106.6% | 3.9% | 2.3% | 4.6% | 9.7% | 8.4% | 12.8% | 12.5% | — |
| Valuation | |||||||||||||||||||
| P/E | 0.80 | 0.80 | — | — | 13.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 5.52 | 5.52 | 11.70 | 8.14 | 7.39 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | -1.2% | -1.2% | 1.2% | 2.3% | — | 4.9% | -10.8% | -6.7% | -7.8% | -16.7% | — | — | — | — | — | — | — | — | — |
| EPS Growth | 196.7% | 196.7% | -282.4% | -391.4% | — | -59.9% | 174.0% | 15.2% | 68.2% | -41.6% | -1234.3% | 67.1% | -34.3% | -49.0% | 32.7% | -25.9% | 13.2% | 14.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-59.8%
EPS terminal req.
$0.24
Spread vs growth
256.5%
5Y implied EPS CAGR
-39.9%
EPS terminal req.
$0.30
Spread vs growth
236.6%
10Y implied EPS CAGR
-18.7%
EPS terminal req.
$0.48
Spread vs growth
215.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-28.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.90 → 3.77
Residual
-28.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.